SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001157523-12-002801
Filing Date
2012-05-11
Accepted
2012-05-11 08:30:56
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 OPEXA THERAPEUTICS, INC. 10-Q a50266973.htm 10-Q 433276
2 EXHIBIT 31.1 a50266973_ex311.htm EX-31.1 14753
3 EXHIBIT 32.1 a50266973_ex321.htm EX-32.1 6954
4 LOGO logo.jpg GRAPHIC 1819
  Complete submission text file 0001157523-12-002801.txt   1456807

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT opxa-20120331.xml EX-101.INS 101467
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opxa-20120331.xsd EX-101.SCH 12208
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opxa-20120331_cal.xml EX-101.CAL 27419
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opxa-20120331_def.xml EX-101.DEF 65481
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opxa-20120331_lab.xml EX-101.LAB 95401
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opxa-20120331_pre.xml EX-101.PRE 76696
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33004 | Film No.: 12832227
SIC: 2834 Pharmaceutical Preparations